story of the week
Risk of Adverse Pathology at Prostatectomy in the Era of MRI and Targeted Biopsies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Urologic Oncology: Seminars and Original Investigations
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Adverse Pathology at Prostatectomy in the Era of MRI and Targeted Biopsies; Rethinking Active Surveillance for Intermediate-Risk Prostate Cancer Patients
Urol. Oncol 2021 Mar 15;[EPub Ahead of Print], JB Bloom, MA Daneshvar, AH Lebastchi, M Ahdoot, SA Gold, G Hale, S Mehralivand, T Sanford, V Valera, BJ Wood, PL Choyke, MJ Merino, B Turkbey, HL Parnes, PA PintoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.